Medication assistance programs: do all in need benefit equally
dc.contributor.author | Pisu, Maria | |
dc.contributor.author | Crenshaw, Katie | |
dc.contributor.author | Funkhouser, Ellen M. | |
dc.contributor.author | Ray, Midge N. | |
dc.contributor.author | Kiefe, Catarina I. | |
dc.contributor.author | Saag, Kenneth G. | |
dc.contributor.author | LaCivita, Cynthia L. | |
dc.contributor.author | Allison, Jeroan J. | |
dc.date | 2022-08-11T08:10:33.000 | |
dc.date.accessioned | 2022-08-23T17:12:35Z | |
dc.date.available | 2022-08-23T17:12:35Z | |
dc.date.issued | 2010-11-01 | |
dc.date.submitted | 2012-04-16 | |
dc.identifier.citation | Ethn Dis. 2010 Autumn;20(4):339-45. | |
dc.identifier.issn | 1049-510X (Linking) | |
dc.identifier.pmid | 21305819 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/46536 | |
dc.description.abstract | OBJECTIVE: To determine if medication assistance programs (MAPs) provided by pharmaceutical companies were used differently by African Americans and Whites. RESEARCH DESIGN: A cross-sectional survey was conducted among patients of primary care practices from 2005 to 2007 within the Alabama Nonsteroidal Anti-Inflammatory Drug (NSAID) Patient Safety Study. SETTING: Telephone survey. PARTICIPANTS: Respondents were 568 African American and White patients reporting annual household incomes < $50,000. MAIN OUTCOME MEASURE: Use of MAPs. RESULTS: Of all patients, 12.8% used MAPs, 39.5% were African American, 75.2% were female, 69.1% were aged > 65 years, 79.8% had annual household incomes < $25,000, and 35.5% indicated that their income was inadequate to meet their basic needs. MAPs were used by 11.2% African-Americans and 14.0% Whites. After multivariable adjustment, MAP use was higher among respondents with incomes not adequate to meet basic needs (odds ratio [OR]: 2.19, 95% confidence interval [CI]: 1.17-4.08) but lower among African Americans than Whites (OR: 0.49, 95% CI: 0.25-0.95). Physician characteristics did not independently predict MAP use. CONCLUSIONS: Overall MAP use was low even among the most vulnerable, and especially among African Americans. As currently used, MAPs may contribute to disparities in medication access. | |
dc.language.iso | en_US | |
dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=21305819&dopt=Abstract">Link to Article in PubMed</a> | |
dc.relation.url | http://www.ishib.org/journal/20-4/ethn-20-04-339.pdf | |
dc.subject | African Americans | |
dc.subject | Aged | |
dc.subject | Alabama | |
dc.subject | Cross-Sectional Studies | |
dc.subject | Drug Industry | |
dc.subject | Drug Prescriptions | |
dc.subject | European Continental Ancestry Group | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Logistic Models | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Social Welfare | |
dc.subject | Biostatistics | |
dc.subject | Epidemiology | |
dc.subject | Health Services Research | |
dc.title | Medication assistance programs: do all in need benefit equally | |
dc.type | Journal Article | |
dc.source.journaltitle | Ethnicity and disease | |
dc.source.volume | 20 | |
dc.source.issue | 4 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/qhs_pp/1003 | |
dc.identifier.contextkey | 2767206 | |
html.description.abstract | <p>OBJECTIVE: To determine if medication assistance programs (MAPs) provided by pharmaceutical companies were used differently by African Americans and Whites.</p> <p>RESEARCH DESIGN: A cross-sectional survey was conducted among patients of primary care practices from 2005 to 2007 within the Alabama Nonsteroidal Anti-Inflammatory Drug (NSAID) Patient Safety Study.</p> <p>SETTING: Telephone survey.</p> <p>PARTICIPANTS: Respondents were 568 African American and White patients reporting annual household incomes < $50,000.</p> <p>MAIN OUTCOME MEASURE: Use of MAPs.</p> <p>RESULTS: Of all patients, 12.8% used MAPs, 39.5% were African American, 75.2% were female, 69.1% were aged > 65 years, 79.8% had annual household incomes < $25,000, and 35.5% indicated that their income was inadequate to meet their basic needs. MAPs were used by 11.2% African-Americans and 14.0% Whites. After multivariable adjustment, MAP use was higher among respondents with incomes not adequate to meet basic needs (odds ratio [OR]: 2.19, 95% confidence interval [CI]: 1.17-4.08) but lower among African Americans than Whites (OR: 0.49, 95% CI: 0.25-0.95). Physician characteristics did not independently predict MAP use.</p> <p>CONCLUSIONS: Overall MAP use was low even among the most vulnerable, and especially among African Americans. As currently used, MAPs may contribute to disparities in medication access.</p> | |
dc.identifier.submissionpath | qhs_pp/1003 | |
dc.contributor.department | Department of Quantitative Health Sciences | |
dc.source.pages | 339-45 |